Nanosonics Limited

ASX:NAN ISIN:AU000000NAN9

Nanosonics Limited is developing a portfolio of decontamination products designed to reduce the spread of infection. The Company owns intellectual property relating to a unique disinfection and sterilisation technology which can be suited to a variety of markets.<br /><br />Initial market applications are designed for the reprocessing of reusable medical instruments. The Company’s first product is designed to disinfect Ultrasound Transducers. In parallel with the commercialisation of this product, Nanosonics is also developing other medical applications and exploring opportunities for its proprietary technology in other industries. 
 
   

查看其它語言版本

新聞

3月30日亞洲市場縱覽

🕔3/30/2009 3:00:25 PM 22772

美國股市週五回落後,大多數亞洲股市週一交易日開市十分波動。東京和首爾市場開盤平淡,然後很快進入下跌區域。今天投資者也在等待美國政府公佈援助汽車工業的計劃。

閱讀全文
###

37,447 公司背景瀏覽

  • 本頁瀏覽人次: (過去7日: 35) (過去30日: 198) (自發布以來: 9950) 

公司詳細

更多新聞紀錄

  • 2025/08/26: 2025 Full Year Results Investor Presentation*
  • 2025/08/26: 2025 Full Year Financial Results*
  • 2025/08/26: 2025 Annual Report*
  • 2025/08/26: 2025 Sustainability Report*
  • 2025/08/26: Appendix 4G*
  • 2025/08/26: 2025 Corporate Governance Statement*
  • 2025/08/26: Appendix 4E*
  • 2025/08/07: FY25 Full Year Results webinar notification*
  • 2025/08/06: US FDA clearance received for next generation trophon*
  • 2025/07/25: Change in substantial holding*
*refer to company website